O. Reg. 138/18: REPORTS
filed March 29, 2018 under Health Protection and Promotion Act, R.S.O. 1990, c. H.7Skip to content
ontario regulation 138/18
made under the
Health Protection and Promotion Act
Made: March 27, 2018
Filed: March 29, 2018
Published on e-Laws: April 3, 2018
Printed in The Ontario Gazette: April 14, 2018
Amending Reg. 569 of R.R.O. 1990
1. (1) Subsections 1 (2) and 3.1 (1) of Regulation 569 of the Revised Regulations of Ontario, 1990 are amended by striking out “reportable disease” wherever it appears and substituting in each case “disease of public health significance”.
(2) Paragraph 6 of subsection 3.1 (2) of the Regulation is amended by striking out “reportable” and substituting “disease of public health significance”.
2. (1) Paragraph 4 of section 5 of the Regulation is amended by striking out “Lassa Fever, Hemorrhagic fevers including” in the portion before subparagraph i and substituting “Hemorrhagic fevers, including Lassa Fever”.
(2) Paragraph 5 of section 5 of the Regulation is amended by striking out “Haemophilus influenzae b disease, invasive” in the portion before subparagraph i and substituting “Haemophilus influenza, all types, invasive,”.
(3) Paragraph 8 of section 5 of the Regulation is revoked.
(4) Paragraph 12 of section 5 of the Regulation is revoked and the following substituted:
12. Gastroenteritis and respiratory infection outbreaks in institutions and public hospitals:
i. The name and address of the institution or hospital, as the case may be, and the contact person.
ii. The agent of disease, if known.
iii. The onset date and clinical details of symptoms in first and last cases.
iv. A description of the outbreak and an outbreak definition, including, without being limited to, a description of symptoms and laboratory findings.
v. The date the outbreak was declared and the outbreak number, if applicable.
vi. The date the outbreak was declared over.
vii. The total number of cases in residents or patients and all persons who carry on activities in the facility, including, but not limited to, employees, nurses, students, physicians, registered nurses in the extended class, contract workers and volunteers.
viii. The total number of cases in residents and staff of the institution who were admitted to hospital.
ix. The total number of outbreak-related deaths during the outbreak period.
x. Laboratory findings (etiologic agent/subtyping).
xi. Current treatment, if any, of the residents of the institution exhibiting signs and symptoms consistent with the outbreak, setting out the drugs used and the date treatment commenced.
xii. Measures taken to monitor the institution for signs and symptoms consistent with the outbreak in persons who are residents or staff of the institution, including the line list which shall include the name and location of residents and staff within the institution exhibiting signs and symptoms consistent with the description of the outbreak, including clinical details and when the symptoms commenced.
xiii. Number of residents and staff in the entire institution and in areas of the institution affected by the outbreak.
xiv. The details of any notification made to any other institution or hospital regarding the declaration of an outbreak in the institution or hospital for the purposes of preventing the spread of infection.
xv. Infection control measures utilized to minimize the impact of the outbreak on the residents and staff of the institution and to prevent the spread of the infection, including, but not limited to, influenza immunization, exclusion of non-immunized persons from the institution, the use of antiviral medications, isolation of ill persons, increased environmental sanitation and restriction of visitors.
xvi. For outbreaks in institutions, verification of staff immunization policies.
(5) Paragraph 16 of section 5 of the Regulation is amended by adding “Blastomycosis” after “Anthrax”, by adding “Echinococcus multilocularis infection” after “Cyclosporiasis” and by striking out “Gastroenteritis, institutional outbreaks” in the portion before subparagraph i.
3. The Regulation is amended by adding the following section:
5.3 A report under subsection 27 (1) of the Act in respect of Carbapenemase-producing Enterobacteriaceae (CPE), infection or colonization, shall contain the following information in addition to the information required under subsection 1 (1):
1. The date of the diagnosis.
2. The agent of disease.
3. The name and address of the physician or registered nurse in the extended class attending the person.
4. The name of the hospital and the date of admission and the date of discharge if the person is admitted to hospital or the name of the hospital if the person is seen as an out-patient of the hospital.
5. The case classification of the person.
6. Laboratory findings and investigative tests, including, without being limited to, type of specimen, culture and antimicrobial sensitivity, serological tests, microscopic examination and cerebrospinal fluid examination, together with the results of the tests.
7. Association with outbreak and outbreak number, if applicable.
8. Risk factors, including exposure to known reservoirs or vectors, as applicable.
9. Travel history, both within and outside Canada.
10. Hospitalization history outside Canada.
11. The outcome of the disease.
12. The date of death and relation of the infection to the cause of death, if the person is deceased.
4. (1) Paragraph 11 of Schedule 1 to the Regulation is revoked.
(2) Schedule 1 to the Regulation is amended by adding the following paragraph:
25.1 Oxford Elgin St. Thomas Health Unit, 1230 Talbot Street, St. Thomas.
5. (1) Subject to subsection (2), this Regulation comes into force on the later of the day subsection 14 (4) of Schedule 3 to the Strengthening Quality and Accountability for Patients Act, 2017 comes into force and the day this Regulation is filed.
(2) Section 4 comes into force on the later of the day subsection 1 (4) of Schedule 3 to the Strengthening Quality and Accountability for Patients Act, 2017 comes into force and the day this Regulation is filed.